Bristol-Myers Squibb is undervalued with a 5%+ dividend yield, robust pipeline, and recession-resistant business. Click here ...

Atypical antipsychotic drugs are less likely to induce neurologic side effects compared with typical (conventional) antipsychotics, such as haloperidol. Some recent, large-scale studies have shown ...

However, adjunctive use of the first-in-class antipsychotic did show a numerical improvement compared with treatment with placebo and an atypical antipsychotic, Bristol Myers Squibb reported in a ...

The primary objective is to assess the efficacy of Cobenfy as an adjunctive treatment to one of several atypical antipsychotics compared to placebo with an atypical antipsychotic as measured by ...

Bristol Myers Squibb's Cobenfy as an adjunctive treatment did not reach the threshold for a statistically significant difference compared to a placebo with an atypical antipsychotic in adults with ...

Cobenfy as an adjunctive treatment to atypical antipsychotics failed to show superior efficacy versus placebo with atypicals when used in patients with inadequately controlled schizophrenia ...

All the newer atypical antipsychotics tested cause weight gain, some more than others. Patients with major depressive disorder also frequently require long-term drug treatment, especially those ...

The trial evaluated Cobnefy as an add-on therapy to existing atypical antipsychotics in adults with uncontrolled schizophrenia symptoms, according to an April 22 news release from the drugmaker.

SZA leads with double the power on both the albums and songs charts as her “SOS” LP returns to the top of the album chart for a 13th nonconsecutive week. Her’s and Kendrick Lamar’s ...